Clinical Trials on Morphine Metabolism

Total 54707 results

Enzymotec

Completed

Effect of Plant Sterols Esterified to Fish Oil Fatty Acids on Plasma Lipid Levels

Dyslipidemia

Israel
AstraZeneca

Completed

Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea (CRESENDO)

Dyslipidemia

Korea, Republic of
Sheba Medical Center

Unknown

Fetal Parenchymatic Evaluation (Liver, Spleen) Using T2* Sequences

Iron Overload

Israel
Hospital de Clinicas de Porto Alegre

Completed

Effect of Eggplant Extract on Lipid Profile During Fasting and Postprandial Period

Dyslipidemia

Brazil
CHU de Quebec-Universite Laval
AstraZeneca

Completed

Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia

Dyslipidemia

Canada
Westlake University

Completed

Westlake N-of-1 Trials for Macronutrient Intake (WE-MACNUTR)

Postprandial Hyperglycemia | Metabolic Disorder, Glucose

China
Sansum Diabetes Research Institute
Novo Nordisk A/S

Terminated

Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care

Diabetes Mellitus, Type 2 | Glucose Metabolism Disorders (Including Diabetes Mellitus)

United States
Jerry Vockley, MD, PhD
Ultragenyx Pharmaceutical Inc

Recruiting

Study of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Medium-chain Acyl-CoA Dehydrogenase Deficiency

United States
Centre Hospitalier Universitaire de la Réunion

Recruiting

Assess the Possibility of Diagnosing Diabetes and Rediabetes Following Oral Induced Hyperglycemia in Patients With Dunnigan's Partial Familial Lipodystrophy by Replacing 75 g of Glucose With a Standardized Carbohydrate Breakfast and Continuous Interstitial Monitoring Glucose) (HGPO-DUN)

Lipodystrophy

Réunion
Ludwig-Maximilians - University of Munich
Bayer

Completed

Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients (METATEL)

Hypertension | Metabolic Syndrome | Hypertriglyceridemia

Germany
UMC Utrecht

Completed

Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Function

Metabolic Syndrome

Netherlands
Dr. Schär AG / SPA

Completed

Market Research - Acceptability Study for a New PKU Protein Substitute

Phenylketonurias | Inborn Errors of Metabolism | Metabolic Disease | PKU

United Kingdom
AstraZeneca
AstraZeneca K.K.

Recruiting

A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia (PURSUIT)

Dyslipidemia

Denmark, Hungary, Spain, United States, Japan, Czechia, Slovakia, Canada
Yonsei University

Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia

Dyslipidemia

Korea, Republic of
Dongkwang Pharm. Co., Ltd.

Not yet recruiting

Phase 3 Trial to Evaluate the Efficacy and Safety of DKP21102_B Added on to DKP21102_A Compared With DKP21102_A

Dyslipidemias
Daewoong Pharmaceutical Co. LTD.

Not yet recruiting

Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507

Dyslipidemias
Adrian Vella
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetics

Healthy

United States
Hospices Civils de Lyon

Recruiting

From Known to New Genes in Dyslipidemia (GENELIP)

Dyslipidemias

France
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391

Dyslipidemias

Korea, Republic of
Amgen

Completed

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension (FOURIER OLE)

Dyslipidemia

United States, Poland, Czechia, Hungary, Russian Federation, Ukraine, Slovakia
Abbott

Completed

A Clinical Study to Evaluate the Effect of Mobile Applications "My A:Care" and "Smart Coach" on the Lipid-lowering Treatment Adherence of Subjects With Dyslipidemia in Thailand (My A:Care)

Dyslipidemia

Thailand
Sun Yat-sen University

Completed

A Dose-response Study of Dietary Resveratrol on Lipid Metabolism Disorder

Dyslipidemias

China
BTL Industries Ltd.

Completed

Non-invasive Lipolysis and Improvement of Muscle Tone in Upper Arms

Fat Disorder

United States
Eli Lilly and Company

Completed

A Study of LY3561774 in Participants With Dyslipidemia

Dyslipidemias

United States
Kowa Company, Ltd.

Completed

A Phase III Long Term Study of K-877 Extended Release Tablet

Dyslipidemias

Japan
Dr. Anatoly Langer
Amgen

Active, not recruiting

GOAL International QuERI - Protocol CHRC 2019 GOAL INTERNATIONAL (GOAL QuERI)

Dyslipidemia

Kuwait, Mexico, Saudi Arabia, United Arab Emirates
Laboratorios Silanes S.A. de C.V.

Completed

Study to Evaluate the Safety of the Fixed-dose Combination Rosuvastatin/Ezetimibe for Patients With Dyslipidaemia (TREZETE)

Dyslipidemias

Mexico
Organon and Co

Completed

Retrospective Survey Evaluating the Effectiveness and Safety of Dual Inhibition Lipid-lowering in the Treatment of Dyslipidemia (Study P05171)(COMPLETED)

Dyslipidemia
BTL Industries Ltd.

Completed

Non-invasive Lipolysis and Improvement of Muscle Tone in Inner Thighs

Fat Disorder

United States
Yooyoung Pharmaceutical Co., Ltd.

Completed

Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-A

Dyslipidemias

Korea, Republic of
University of Colorado, Denver
American Society of Health-System Pharmacists

Withdrawn

Glucose Variability in Cancer Patients Receiving Dexamethasone

Hyperglycemia | Cancer

United States
Abbott

Completed

Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patients Under the "New Drug Re-examination".

Dyslipidemias

Korea, Republic of
Sun Yat-sen University

Completed

Dietary Anthocyanins Improve Lipid Metabolism in a Dose - Dependent Manner

Dyslipidemias

China
University of Pennsylvania
National Heart, Lung, and Blood Institute (NHLBI); Arizona Pharmaceuticals...

Completed

Effects of Niacin On Fatty Acid Trapping (NOFAT)

Dyslipidemia

United States
Veloxis Pharmaceuticals

Completed

12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia

Dyslipidemia

United States
Canadian Heart Research Centre
Amgen

Completed

Guidelines Oriented Approach to Lipid Lowering (GOAL) in Canada (GOAL)

Dyslipidemia
University of Minnesota
Laval University

Completed

Fenofibrate and Pharmacogenetic Impact in Dyslipidemia (FPI)

Dyslipidemia

United States
Aga Khan University
Muhammad Safdar Ali

Unknown

Effect of Aerobic Training and Moringa Oleifera on Dyslipidemia and Cardiac Endurance

Dyslipidemias
NorthSea Therapeutics B.V.

Completed

A Study to Evaluate the Effects of NST-4016 on QT/Corrected QT (QTc) Interval

Dyslipidemias

United Kingdom
Children's Mercy Hospital Kansas City

Completed

Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients (SD2)

Dyslipidemia

United States
Kathryn Beardsall

Completed

Point of Care Ketone Measurement in the Newborn (POCKET)

Hypoglycaemia

United Kingdom
Uppsala University

Completed

Fatty Acid Biomarkers of Carbohydrate Intake (CARBIO)

Dyslipidemias

Sweden
Eli Lilly and Company

Completed

A Study of Evacetrapib in Participants With Abnormal Cholesterol

Dyslipidemia

United States
Shaheed Zulfiqar Ali Bhutto Medical University

Unknown

Effect of Adding Folic Acid on Lipid Parameters in Population With Dyslipidemias

Dyslipidemias

Pakistan
Amgen

Completed

Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects (EBBINGHAUS)

Dyslipidemia

United States, Belgium, Denmark, Finland, France, Italy, Spain, Hungary, Poland, Germany, Czechia, Turkey, United Kingdom, Malaysia, Australia, Hong Kong, New Zealand, Canada, South Africa, Greece, Portugal, Netherlands, Russian Federation and more
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

Dyslipidemias

Korea, Republic of
Yooyoung Pharmaceutical Co., Ltd.

Unknown

Prospective Observational Study of Pravafenix Cap

Dyslipidemias

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519

Dyslipidemia

Korea, Republic of
Sun Yat-sen University

Completed

The Effects of Dietary Supplement of Coenzyme Q10（CoQ10） on Dyslipidemia (TEDSCD)

Dyslipidemia

China
Hospital de Clinicas de Porto Alegre

Completed

Effects of Two Aquatic Training Models in Physiological Parameters of Elderly Dyslipidemic Women.

Dyslipidemias

3

Subscribe